Ghent University Hospital
🇧🇪Belgium
Study of Biomarkers of Immune Activation Associated With Symptoms and Immune Responses After Influenza Vaccination in Adults
Phase 4
Completed
- Conditions
- Prevention of Influenza
- Interventions
- Drug: Seasonal,quadrivalent,influenza vaccine
- First Posted Date
- 2017-05-19
- Last Posted Date
- 2022-01-24
- Lead Sponsor
- University Hospital, Ghent
- Target Recruit Count
- 20
- Registration Number
- NCT03160118
- Locations
- 🇧🇪
University Hospital - Center for Vaccinology, Ghent, East-Flanders, Belgium
The Inflammatory Response to Stress and Angiogenesis in Liver Resection
Not Applicable
Completed
- Conditions
- Liver MetastasesLiver CancerColorectal CancerMetastatic Cancer
- Interventions
- Procedure: Liver resection
- First Posted Date
- 2017-04-27
- Last Posted Date
- 2017-05-01
- Lead Sponsor
- University Hospital, Ghent
- Target Recruit Count
- 40
- Registration Number
- NCT03131778
Outcome of 15 Versus 5 Fractions in Adjuvant Breast Radiotherapy in Women Over 65 Years
Not Applicable
Active, not recruiting
- Conditions
- Breastcancer
- Interventions
- Radiation: WBI 15 fractionsRadiation: WBI 5 fractionsRadiation: LNI 15 fractionsRadiation: LNI 5 fractionsRadiation: TWI 15 fractionsRadiation: SIB 15 fractions if neededRadiation: TWI 5 fractionsRadiation: SIB 5 fractions if needed
- First Posted Date
- 2017-04-20
- Last Posted Date
- 2023-12-22
- Lead Sponsor
- University Hospital, Ghent
- Target Recruit Count
- 144
- Registration Number
- NCT03121248
- Locations
- 🇧🇪
Ghent University Hospital, Dept. Radiotherapy-Oncology, Ghent, Belgium
CMV Specific T Cell Therapy After Allogeneic Stem Cell Transplantation.
Phase 2
Completed
- Conditions
- CMV InfectionHematological Malignancies
- Interventions
- Genetic: CMV-specific T cellsDrug: Standard anti-viral therapy
- First Posted Date
- 2017-03-01
- Last Posted Date
- 2022-12-21
- Lead Sponsor
- University Hospital, Ghent
- Target Recruit Count
- 1
- Registration Number
- NCT03067155
- Locations
- 🇧🇪
Universitair Ziekenhuis Gent, Gent, Oost-Vlaanderen, Belgium
🇧🇪Institut Jules Bordet, Brussel, Belgium
🇧🇪Universitair Ziekenhuis Brussel, Brussel, Belgium
Laser Assisted Drug Delivery in the Treatment of Superficial Non Melanoma Skin Cancer: a Randomized Controlled Trial
Not Applicable
Completed
- Conditions
- Bowen's DiseaseSuperficial Basal Cell Carcinoma
- Interventions
- Device: full ablative CO2 laserDevice: fractional ablative CO2 laserDrug: MALDevice: LED lamp
- First Posted Date
- 2017-01-06
- Last Posted Date
- 2018-01-25
- Lead Sponsor
- University Hospital, Ghent
- Target Recruit Count
- 16
- Registration Number
- NCT03012009
- Locations
- 🇧🇪
Department of Dermatology, Ghent University Hospital, Ghent, Belgium
DetermInants of Antimicrobial Use aNd De-escalAtion in Critical Care (DIANA)
Completed
- Conditions
- Infection
- First Posted Date
- 2016-09-30
- Last Posted Date
- 2019-09-20
- Lead Sponsor
- University Hospital, Ghent
- Target Recruit Count
- 1495
- Registration Number
- NCT02920463
- Locations
- 🇧🇪
Ghent University Hospital, Ghent, Belgium
Study to Analyse Difference in Bioavailability Between MP29-02 and Fluticasone Propionate
Not Applicable
Withdrawn
- Conditions
- Bioavailability Study
- Interventions
- First Posted Date
- 2016-08-30
- Last Posted Date
- 2021-07-13
- Lead Sponsor
- University Hospital, Ghent
- Registration Number
- NCT02883439
- Locations
- 🇧🇪
University Hospital Ghent, departement otorhinolaryngology, Ghent, Belgium
Trial of Stereotactic Body Radiotherapy With Concurrent Pembrolizumab in Metastatic Urothelial Cancer
- First Posted Date
- 2016-07-11
- Last Posted Date
- 2024-07-17
- Lead Sponsor
- University Hospital, Ghent
- Target Recruit Count
- 18
- Registration Number
- NCT02826564
- Locations
- 🇧🇪
University Hospital Ghent, Ghent, Belgium
A Phase II Trial of Stereotactic Body Radiotherapy With Concurrent Anti-PD1 Treatment in Metastatic Melanoma.
Phase 2
Completed
- Conditions
- Melanoma
- Interventions
- Radiation: stereotactic body radiotherapy
- First Posted Date
- 2016-07-01
- Last Posted Date
- 2022-12-29
- Lead Sponsor
- University Hospital, Ghent
- Target Recruit Count
- 20
- Registration Number
- NCT02821182
- Locations
- 🇧🇪
University Hospital Ghent, Gent, West Vlaanderen, Belgium
RANKL-blockade for the Treatment of Erosive Osteoarthritis (OA) of Interphalangeal Finger Joints
Phase 2
Completed
- Conditions
- Hand Osteoarthritis
- Interventions
- First Posted Date
- 2016-05-13
- Last Posted Date
- 2021-05-26
- Lead Sponsor
- University Hospital, Ghent
- Target Recruit Count
- 100
- Registration Number
- NCT02771860
- Locations
- 🇧🇪
UZ Ghent, Gent, Belgium
© Copyright 2025. All Rights Reserved by MedPath